As of Jul 02
| -0.17 / -0.36%|
The 9 analysts offering 12-month price forecasts for Seattle Genetics Inc have a median target of 41.00, with a high estimate of 65.00 and a low estimate of 26.00. The median estimate represents a -13.96% decrease from the last price of 47.65.
The current consensus among 12 polled investment analysts is to Hold stock in Seattle Genetics Inc. This rating has held steady since June, when it was downgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.